Mets: 3 overpaid players we need to break up with immediately

NEW YORK, NEW YORK - AUGUST 01: Carlos Carrasco #59 of the New York Mets looks on against the Cincinnati Reds at Citi Field on August 01, 2021 in New York City. The Reds defeated the Mets 7-1. (Photo by Jim McIsaac/Getty Images)
NEW YORK, NEW YORK - AUGUST 01: Carlos Carrasco #59 of the New York Mets looks on against the Cincinnati Reds at Citi Field on August 01, 2021 in New York City. The Reds defeated the Mets 7-1. (Photo by Jim McIsaac/Getty Images) /
facebooktwitterreddit
Prev
2 of 3
Next
PORT ST. LUCIE, FL – MARCH 11: Robinson Cano #24 of the New York Mets in action against the St. Louis Cardinals during a spring training baseball game at Clover Park at on March 11, 2020 in Port St. Lucie, Florida. (Photo by Rich Schultz/Getty Images)
PORT ST. LUCIE, FL – MARCH 11: Robinson Cano #24 of the New York Mets in action against the St. Louis Cardinals during a spring training baseball game at Clover Park at on March 11, 2020 in Port St. Lucie, Florida. (Photo by Rich Schultz/Getty Images) /

2. Robinson Cano

The 39-year-old Robinson Cano has had an impressive MLB career spanning two decades, filling his trophy case with World Series, Gold Glove, Silver Slugger and All-Star titles.

But Cano’s short career with the Mets so far has been an utter disappointment, to put it politely. The five-time Silver Slugger saw career-lows in 2019, batting .256/.307/.428 and 39 RBIs, the worst of his decorated career. Mike Mazzeo of the New York Post described the situation as “an unmitigated disaster“, which is an accurate way of describing a contract that pays Cano $24 million per year.

While Cano bounced back in the pandemic-shortened season, it was soon revealed why that was the case: Cano tested for performance-enhancing drugs on Nov. 18 of last year. Since then, Cano has been suspended for 162 games, which included the entirety of the 2021 season.

Cano didn’t even play in 2021, but he is still slated to earn $24 million in 2022 and 2023. Cano turns 40 next October, and if he is already utilizing performance-enhancing drugs at 38, it’s difficult to imagine Cano overcoming the cliff with the same batting power he once possessed.

It’s a bad situation, both for Cano and the Mets, and it’s difficult to imagine how they could get out of this one without losing out. If Eppler can manage a trade for Cano, it would be better to get him off the books instead of handing him another $24 million.